Skip to content

Clinical trials

Completed Hypertension trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension Status: Completed Country / region: Hong Kong Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20052
20063
20071
20081
20101
20123
20131
20141
20161
20183
20193
20202
20212
20221
20233
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed31

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese University of Hong Kong12
The University of Hong Kong4
Boehringer Ingelheim3
Novartis Pharmaceuticals2
Sanofi2
AstraZeneca1
CSL Behring1
Education University of Hong Kong1
Hong Kong Metropolitan University1
Kwong Wah Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension31
Diabetes Mellitus3
Stroke3
Hyperlipidemias2
Acute Coronary Syndrome1
Atherosclerosis1
Atrial Fibrillation1
Cardiovascular Diseases1
Cerebral Hemorrhage1
Coronary Artery Disease1

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.